Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.793170
Title: The phamacokinetics of medical countermeasures against nerve agents
Author: Armstrong, Stuart
ISNI:       0000 0004 8501 6078
Awarding Body: University of Southampton
Current Institution: University of Southampton
Date of Award: 2014
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
Nerve agents are organophosphorus compounds that irreversibly inhibit acetylcholinesterase, causing accumulation of the neurotransmitter acetylcholine and this excess leads to an overstimulation of acetylcholine receptors. Inhalation exposure to nerve agent can be lethal in minutes and conversely, skin exposure may be lethal over longer durations. Medical Countermeasures (MedCM) are fielded in response to the threat posed by nerve agents. MedCM with improved efficacy are being developed but the efficacy of these cannot be tested in humans, so their effectiveness is proven in animals. It is UK Government policy that all MedCM are licensed for human use. The aim of this study was to test the hypothesis that the efficacy of MedCM against nerve agent exposure by different routes could be better understood and rationalised through knowledge of the MedCM pharmacokinetics (PK). The PK of MedCM was determined in naïve and nerve agent poisoned guinea pigs. PK interactions between individual MedCM drugs when administered in combination were also investigated. In silico simulations to predict the concentration-time profiles of different administration regimens of the MedCM were completed using the PK parameters determined in vivo. These simulations were used to design subsequent in vivo PK studies and to explain or predict the efficacy or lack thereof for the MedCM. The PK data generated in this study are the first such data in conscious guinea pigs, the small animal species of choice for determination of MedCM efficacy. These data show how PK can improve the understanding of MedCM efficacy. PK studies such as those reported here should be integrated into the development programmes of future MedCM.
Supervisor: Green, Chris ; Clough, Geraldine Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.793170  DOI: Not available
Share: